A detailed history of High Tower Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, High Tower Advisors, LLC holds 168,341 shares of OGN stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
168,341
Previous 169,369 0.61%
Holding current value
$3.08 Million
Previous $3.18 Million 9.42%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $17,938 - $22,574
-1,028 Reduced 0.61%
168,341 $3.48 Million
Q1 2024

May 06, 2024

BUY
$13.78 - $18.8 $477,656 - $651,664
34,663 Added 25.73%
169,369 $3.18 Million
Q4 2023

Feb 12, 2024

BUY
$10.95 - $17.32 $566,366 - $895,842
51,723 Added 62.33%
134,706 $1.94 Million
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $3,251 - $4,658
-196 Reduced 0.24%
82,983 $1.44 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $128,164 - $163,814
-6,651 Reduced 7.4%
83,179 $1.73 Million
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $126,270 - $189,111
-5,895 Reduced 6.16%
89,830 $2.11 Million
Q4 2022

Feb 08, 2023

SELL
$23.31 - $28.61 $265,174 - $325,467
-11,376 Reduced 10.62%
95,725 $2.67 Million
Q3 2022

Nov 09, 2022

BUY
$23.4 - $34.25 $128,933 - $188,717
5,510 Added 5.42%
107,101 $2.44 Million
Q2 2022

Aug 10, 2022

SELL
$31.66 - $38.9 $60,407 - $74,221
-1,908 Reduced 1.84%
101,591 $3.4 Million
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $50,333 - $65,062
-1,653 Reduced 1.57%
103,499 $3.55 Million
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $230,420 - $298,413
-8,037 Reduced 7.1%
105,152 $3.17 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $198,692 - $247,341
-6,940 Reduced 5.78%
113,189 $3.63 Million
Q2 2021

Aug 06, 2021

BUY
$28.45 - $38.0 $3.42 Million - $4.56 Million
120,129 New
120,129 $3.48 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.65B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.